 Systemic toxicity ropivacaine ovine pregnancy Ropivacaine new amide local anesthetic potency duration action similar bupivacaine therapeutic index pregnancy cardiotoxicity bupivacaine current study toxicity ropivacaine nonpregnant pregnant ewes continuous intravenous infusion drug rate animals symptoms local anesthetic toxicity usual order convulsions hypotension apnea circulatory collapse significant differences groups animals doses plasma concentrations ropivacaine toxic manifestations example circulatory collapse mean dose nonpregnant pregnant animals plasma concentrations significant Protein binding ropivacaine concentration range toxic manifestations similar sera nonpregnant pregnant ewes conclusion ovine pregnancy systemic toxicity ropivacaine absence gestation-related increase availability free drug